100% Clinical Benefit Rate Achieved in Phase 1b Trial Evaluating APVO436 in Combination with Venetoclax and Azacitidine for Venetoclax Treatment Naïve Patients with Acute Myeloid Leukemia (AML)

Aptevo Therapeutics Plans a Phase 2 Trial in 2H23 in Frontline and Relapsed/Refractory Patients who are Venetoclax Treatment NaïveData Demonstrating APVO436 to be Safe and Well-Tolerated and Clinically Active Among AML Patients in Both Combination and Monotherapy Regimens Presented at the 64th American Society of Hematology (ASH) Annual Meeting and ExpositionSEATTLE…
Read More

What's Hot

Canada’s payroll employment increases, as strong hiring continues

CHP investigates locally acquired SARS-CoV-2 virus cases with 493 cases tested positive by nucleic acid tests and 2 869 cases by RATs as well as 118 imported cases

China Celebrated Lunar New Year Like Covid No Longer Exists

100% Clinical Benefit Rate Achieved in Phase 1b Trial Evaluating APVO436 in Combination with Venetoclax and Azacitidine for Venetoclax Treatment Naïve Patients with Acute Myeloid Leukemia (AML)

Three-drug combination therapy effective in patients with high-risk chronic lymphocytic leukemia, trial shows

32 Gifts for Someone Going Through Chemotherapy, According to People Who’ve Been There 2022

High Rates of pCR With Novel Neoadjuvant Combination for Breast Cancer

Make wishes come true: Shop online on Amazon.sg and ‘cart out’ smiles for children in need

Canada’s payroll employment increases, as strong hiring continues

CHP investigates locally acquired SARS-CoV-2 virus cases with 493 cases tested positive by nucleic acid tests and 2 869 cases by RATs as well as 118 imported cases

China Celebrated Lunar New Year Like Covid No Longer Exists

Holiday trips within China surge after lifting of COVID-19 curbs

Researchers solve an 80-year-old medical mystery that caused baby deaths

Unmet Needs: Critics Cite Failures in Health Care for Vulnerable Foster Children

1 person critically injured in fire at SF apartment complex, SFFD says

Reps, stakeholders advocate establishment of Medical Research Council

5 important health checks to get done this January | Drum

Spurs agree deal for player hours after he passed medical with Everton

What's Hot

100% Clinical Benefit Rate Achieved in Phase 1b Trial Evaluating APVO436 in Combination with Venetoclax and Azacitidine for Venetoclax Treatment Naïve Patients with Acute Myeloid Leukemia (AML)

Related Posts